{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:43:28Z","timestamp":1786707808990,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jiac.2025.102776","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T06:37:53Z","timestamp":1753857473000},"page":"102776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fourth nationwide surveillance of the antimicrobial susceptibility patterns of pathogens isolated from surgical site infections in Japan"],"prefix":"10.1016","volume":"31","author":[{"given":"Norifumi","family":"Shigemoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideji","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiko","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kosai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Morikane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Toiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroji","family":"Shinkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ohge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102776_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1067\/msy.2003.212","article-title":"Surgical complications exert a lasting effect on disease-specific health-related quality of life for patients with colorectal cancer","volume":"134","author":"Anthony","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.jiac.2025.102776_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/jhin.2001.1003","article-title":"Morbidity and mortality associated with surgical site infections: results from the 1997-1999 INCISO surveillance","volume":"48","author":"Astagneau","year":"2001","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jiac.2025.102776_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jamcollsurg.2004.05.276","article-title":"Hospital costs associated with surgical complications: a report from the private-sector national surgical quality improvement program","volume":"199","author":"Dimick","year":"2004","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jiac.2025.102776_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/501572","article-title":"The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs","volume":"20","author":"Kirkland","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2025.102776_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s10156-012-0509-1","article-title":"Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan","volume":"18","author":"Takesue","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jiac.2017.03.010","article-title":"Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: comparison of data from nationwide surveillance studies conducted in 2010 and 2014-2015","volume":"23","author":"Takesue","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jiac.2021.03.010","article-title":"Change in antimicrobial susceptibility of pathogens isolated from surgical site infections over the past decade in Japanese nationwide surveillance study","volume":"27","author":"Ueda","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","author":"Nnis","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jiac.2025.102776_bib10","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2018"},{"key":"10.1016\/j.jiac.2025.102776_bib11","series-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria","year":"2018"},{"key":"10.1016\/j.jiac.2025.102776_bib12","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2023"},{"key":"10.1016\/j.jiac.2025.102776_bib13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jac\/dkh166","article-title":"Characterization of HMRZ-86: a novel chromogenic cephalosporin for the detection of extended-spectrum \u03b2-lactamases","volume":"53","author":"Hanaki","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10096-005-0074-y","article-title":"Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamases","volume":"25","author":"Colodner","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2025.102776_bib17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102776_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10156-010-0086-0","article-title":"Clinical characteristics of vancomycin minimum inhibitory concentration of 2 \u03bcg\/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia","volume":"17","author":"Takesue","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10156-008-0623-2","article-title":"The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese society of chemotherapy. Part 1: a general view of antibacterial susceptibility","volume":"14","author":"Niki","year":"2008","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s10156-009-0674-Z","article-title":"Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese society of chemotherapy in 2007: general view of the pathogens' antibacterial susceptibility","volume":"15","author":"Niki","year":"2009","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10156-011-0214-5","article-title":"Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese society of chemotherapy in 2008: general view of the pathogens' antibacterial susceptibility","volume":"17","author":"Niki","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib22","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/AAC.05186-14","article-title":"Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013","volume":"59","author":"Lob","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the surgical infection society and the infectious diseases society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102776_bib24","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3201\/eid2211.160519","article-title":"Global Escherichia coli sequence type 131 clade with blaCTX-M-27 gene","volume":"22","author":"Matsumura","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2025.102776_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00564-17","article-title":"Occurrence of clinically important lineages, including the sequence type 131 C1-M27 subclone, among extended-spectrum-\u03b2-lactamase-producing Escherichia coli in wastewater","volume":"61","author":"Gomi","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jiac.2016.03.001","article-title":"Community spread of extended-spectrum \u03b2-lactamase-producing bacteria detected in social insurance hospitals throughout Japan","volume":"22","author":"Shibasaki","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jiac.2016.02.004","article-title":"Prevalence and risk factors of infections caused by extended-spectrum \u03b2-lactamase (ESBL)-producing Enterobacteriaceae","volume":"22","author":"Nakai","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jiac.2016.08.010","article-title":"Epidemiology of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli in Japan: characteristics of community-associated versus healthcare-associated ESBL E. coli","volume":"23","author":"Hayakawa","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/sur.2013.189","article-title":"Risk factors for extended spectrum \u03b2-lactamase-producing Escherichia coli versus susceptible E. coli in surgical site infections among cancer patients in Mexico","volume":"15","author":"Montes","year":"2014","journal-title":"Surg Infect"},{"key":"10.1016\/j.jiac.2025.102776_bib30","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1128\/AAC.00701-15","article-title":"Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-\u03b2-lactamase-producing Escherichia coli bacteremia","volume":"59","author":"Matsumura","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib31","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jiac.2025.102776_bib32","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia","volume":"60","author":"Tamma","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102776_bib33","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/cid\/civ097","article-title":"Ceftolozane\/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI)","volume":"60","author":"Solomkin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102776_bib34","first-page":"410","volume":"21","author":"Yanagihara","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib35","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/653053","article-title":"Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia","volume":"51","author":"Jones","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102776_bib36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jiac.2015.05.014","article-title":"Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases","volume":"21","author":"Ishikawa","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0732-8893(01)00254-1","article-title":"Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY antimicrobial surveillance Program (North America)","volume":"40","author":"Mathai","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2025.102776_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jiac.2019.05.006","volume":"25","author":"Yanagihara","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102776_bib39","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1086\/341930","article-title":"Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents","volume":"35","author":"Goldstein","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102776_bib40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/jac\/dkp005","article-title":"Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study","volume":"63","author":"Montravers","year":"2009","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:38:23Z","timestamp":1772883503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25001734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1341321X25001734"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102776","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fourth nationwide surveillance of the antimicrobial susceptibility patterns of pathogens isolated from surgical site infections in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102776"}}